Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Dana Cash
Cotreatment With a Novel Phosphoinositide Analogue Inhibitor and Carmustine Enhances Chemotherapeutic Efficacy by Attenuating AKT Activity in Gliomas
Cancer
Cancer Research
Oncology
Related publications
Inhibition of Constitutively Activated Phosphoinositide 3-Kinase/Akt Pathway Enhances Antitumor Activity of Chemotherapeutic Agents in Breast Cancer Susceptibility Gene 1-Defective Breast Cancer Cells
Molecular Carcinogenesis
Cancer Research
Molecular Biology
Tumor-Targeting Nanodelivery Enhances the Anticancer Activity of a Novel Quinazolinone Analogue
Molecular Cancer Therapeutics
Cancer Research
Oncology
TrkB Inhibition by GNF-4256 Slows Growth and Enhances Chemotherapeutic Efficacy in Neuroblastoma Xenografts
Cancer Chemotherapy and Pharmacology
Cancer Research
Toxicology
Oncology
Pharmacology
Tumor Vessel Normalization After Aerobic Exercise Enhances Chemotherapeutic Efficacy
Oncotarget
Oncology
BIRB796, the Inhibitor of P38 Mitogen-Activated Protein Kinase, Enhances the Efficacy of Chemotherapeutic Agents in ABCB1 Overexpression Cells
PLoS ONE
Multidisciplinary
Sonoporation by Low‑frequency and Low‑power Ultrasound Enhances Chemotherapeutic Efficacy in Prostate Cancer Cells In�vitro
Oncology Letters
Cancer Research
Oncology
Novel ADAM-17 Inhibitor ZLDI-8 Enhances the in Vitro and in Vivo Chemotherapeutic Effects of Sorafenib on Hepatocellular Carcinoma Cells
Cell Death and Disease
Molecular Neuroscience
Immunology
Cell Biology
Cancer Research
Cellular
Medicine
Reduced RKIP Enhances Nasopharyngeal Carcinoma Radioresistance by Increasing ERK and AKT Activity
Oncotarget
Oncology
Cytotoxic Activity of the Novel Akt Inhibitor, MK-2206, in T-Cell Acute Lymphoblastic Leukemia
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
